Get the Stockscreener App
1.17
3.31%
-0.04
Hoth Therapeutics Inc stock is traded at $1.17, with a volume of 70,949.
It is down -3.31% in the last 24 hours and down -8.59% over the past month.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).
See More
Previous Close:
$1.21
Open:
$1.2
24h Volume:
70,949
Relative Volume:
0.10
Market Cap:
$18.15M
Revenue:
-
Net Income/Loss:
$-7.51M
P/E Ratio:
-0.8864
EPS:
-1.32
Net Cash Flow:
$-8.02M
1W Performance:
-2.50%
1M Performance:
-8.59%
6M Performance:
-17.61%
1Y Performance:
+38.13%
1-Day Range:
$1.16
$1.22
1-Week Range:
$1.16
$1.25
52-Week Range:
$0.6554
$3.80
Hoth Therapeutics Inc Stock (HOTH) Company Profile
Name
Hoth Therapeutics Inc
Sector
Industry
Phone
(646)756-2997
Address
1177 AVENUE OF THE AMERICAS, NEW YORK, NY
Compare HOTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOTH
Hoth Therapeutics Inc
|
1.17 | 18.77M | 0 | -7.51M | -8.02M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Hoth Therapeutics Inc Stock (HOTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-19 | Initiated | The Benchmark Company | Speculative Buy |
Hoth Therapeutics Inc Stock (HOTH) Latest News
Sentiment Review: Why Hoth Therapeutics Inc stock remains undervaluedJuly 2025 EndofMonth & Safe Entry Zone Tips - moha.gov.vn
Published on: 2025-12-10 00:57:10 - moha.gov.vn
Hoth Therapeutics (HOTH) Price Target Increased by 12.50% to 4.59 - Nasdaq
D. Boral Capital Maintains Hoth Therapeutics (HOTH) Buy Recommendation - Nasdaq
Hoth Therapeutics stock rises after pipeline update By Investing.com - Investing.com India
Hoth Therapeutics stock rises after pipeline update - Investing.com
Hoth Therapeutics, Inc. Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated Ht-Kit, Advancing Ht-001 Phase 2, and New Gdnf Metabolic Program - MarketScreener
Hoth Therapeutics advances pipeline with four clinical programs By Investing.com - Investing.com India
Hoth Therapeutics advances pipeline with four clinical programs - Investing.com
Hoth Therapeutics Issues Comprehensive Pipeline Update Highlighting Clinical Progress, Orphan-Designated HT-KIT, Advancing HT-001 Phase 2, and New GDNF Metabolic Program - PR Newswire
Hoth Therapeutics to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference, December 2-3, 2025 - Eastern Progress
Bearish Setup: Is Hoth Therapeutics Inc. stock trading near support levelsQuarterly Risk Review & Real-Time Volume Analysis Alerts - moha.gov.vn
Wall Street analysts’ outlook for Hoth Therapeutics Inc (HOTH) - Setenews
What technical signals suggest for Hoth Therapeutics Inc. stockWeekly Trade Report & Fast Entry Momentum Trade Alerts - newser.com
Will Hoth Therapeutics Inc. stock maintain growth storyJuly 2025 Reactions & Consistent Profit Trade Alerts - newser.com
Hoth Therapeutics joins NVIDIA Connect Program to enhance AI research By Investing.com - Investing.com Nigeria
Hoth Therapeutics joins NVIDIA Connect Program to enhance AI research - Investing.com
Hoth Therapeutics accepted into Nvidia Connect Program, expanding its AI and accelerated computing capabilities - MarketScreener
Hoth Therapeutics Accepted Into NVIDIA Connect Program, Expanding Its AI and Accelerated Computing Capabilities - PR Newswire
Can Hoth Therapeutics Inc. stock deliver surprise earnings beat2025 Bull vs Bear & Daily Market Momentum Tracking - newser.com
Can Hoth Therapeutics Inc. stock maintain growth trajectoryQuarterly Profit Review & High Accuracy Buy Signal Tips - newser.com
Is Hoth Therapeutics Inc a good long term investmentVolume Weighted Average Price & Free Superior Profit Margins - earlytimes.in
Can Hoth Therapeutics Inc. stock deliver consistent earnings growth2025 EndofYear Setup & Free High Return Stock Watch Alerts - newser.com
What moving averages say about Hoth Therapeutics Inc.Earnings Beat & Target Return Focused Picks - newser.com
Published on: 2025-11-19 05:13:43 - newser.com
Will Hoth Therapeutics Inc. stock pay special dividendsJuly 2025 EndofMonth & Capital Protection Trading Alerts - newser.com
Why Hoth Therapeutics Inc. stock remains on buy listsRisk Management & Consistent Profit Alerts - newser.com
How to build a dashboard for Hoth Therapeutics Inc. stockJuly 2025 Setups & Expert Curated Trade Setups - newser.com
Will Hoth Therapeutics Inc. rebound enough to break evenGold Moves & Low Risk High Reward Trade Ideas - newser.com
Hoth Therapeutics Inc Stock (HOTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):